Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKBPHAR:LX

67.60 EUR 0.68 1.02%

As of 10:26:15 ET on 03/31/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKBPHAR)

Year To Date: +19.99% 3-Month: +19.99% 3-Year: +30.64% 52-Week Range: 42.16 - 69.06
1-Month: +5.61% 1-Year: +52.56% 5-Year: +20.10% Beta vs MSGUHC: 0.88

Mutual Fund Chart for DKBPHAR

No chart data available.
  • DKBPHAR:LX 67.60
  • 1M
  • 1Y
Interactive DKBPHAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKBPHAR

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 11-22-1999 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKBPHAR

NAV (on 2015-03-31) 67.60
Assets (M) (on 2015-03-31) 49.69
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DKBPHAR

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DKBPHAR

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.82

Top Fund Holdings for DKBPHAR

Filing Date: 02/27/2015
Name Position Value % of Total
Novartis AG 31,933 2,927,102 6.703%
Pfizer Inc 85,500 2,634,507 6.033%
Roche Holding AG 7,850 1,898,792 4.348%
Merck & Co Inc 32,500 1,706,961 3.909%
Gilead Sciences Inc 17,100 1,587,102 3.634%
Sanofi 17,000 1,488,180 3.408%
Amgen Inc 8,900 1,260,340 2.886%
GlaxoSmithKline PLC 57,000 1,216,756 2.786%
AbbVie Inc 22,500 1,213,009 2.778%
UnitedHealth Group Inc 11,800 1,194,737 2.736%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil